{
  "company_number": "07731870",
  "name": "Midland Endocrine And Osteoporosis Limited",
  "url": "/company/07731870",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2011-08-08",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "74909",
      "description": "Other professional, scientific and technical activities n.e.c.",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/74909"
    }
  ],
  "registered_address": {
    "id": 2673435,
    "url": "/address/2673435",
    "line1": "MEARSE FARM HOUSE",
    "line2": "MEARSE FARM LANE INKBERROW",
    "post_town": "WORCESTER",
    "county": "",
    "country": "",
    "postcode": "WR7 4HS"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07731870",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-05-31",
    "last_made_up": "2025-08-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/07731870/accounts/2025-08-31",
        "pdf_url": "/company/07731870/accounts/2025-08-31.pdf",
        "made_up_date": "2025-08-31",
        "period_start": "2025-08-31",
        "period_end": "2025-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "16021.00",
        "debtors": "11980.00",
        "cash_bank_in_hand": "9641.00",
        "current_assets": "21621.00",
        "creditors_due_within_one_year": "15835.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "5786.00",
        "total_assets_less_current_liabilities": "21807.00",
        "net_assets_liabilities": "19495.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "19493.00",
        "shareholder_funds": "19495.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2026.zip"
      },
      {
        "url": "/company/07731870/accounts/2024-08-31",
        "pdf_url": "/company/07731870/accounts/2024-08-31.pdf",
        "made_up_date": "2024-08-31",
        "period_start": "2024-08-31",
        "period_end": "2024-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "13338.00",
        "debtors": "14376.00",
        "cash_bank_in_hand": "1467.00",
        "current_assets": "15843.00",
        "creditors_due_within_one_year": "16686.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-843.00",
        "total_assets_less_current_liabilities": "12495.00",
        "net_assets_liabilities": "10716.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "10714.00",
        "shareholder_funds": "10716.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2025.zip"
      },
      {
        "url": "/company/07731870/accounts/2023-08-31",
        "pdf_url": "/company/07731870/accounts/2023-08-31.pdf",
        "made_up_date": "2023-08-31",
        "period_start": "2023-08-31",
        "period_end": "2023-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "18605.00",
        "debtors": "17193.00",
        "cash_bank_in_hand": "10381.00",
        "current_assets": "27574.00",
        "creditors_due_within_one_year": "14059.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "13515.00",
        "total_assets_less_current_liabilities": "32120.00",
        "net_assets_liabilities": "25883.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "25881.00",
        "shareholder_funds": "25883.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2024.zip"
      },
      {
        "url": "/company/07731870/accounts/2022-08-31",
        "pdf_url": "/company/07731870/accounts/2022-08-31.pdf",
        "made_up_date": "2022-08-31",
        "period_start": "2022-08-31",
        "period_end": "2022-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "25531.00",
        "debtors": "3711.00",
        "cash_bank_in_hand": "7504.00",
        "current_assets": "11215.00",
        "creditors_due_within_one_year": "19461.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-8246.00",
        "total_assets_less_current_liabilities": "17285.00",
        "net_assets_liabilities": "3443.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "3441.00",
        "shareholder_funds": "3443.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2023.zip"
      },
      {
        "url": "/company/07731870/accounts/2021-08-31",
        "pdf_url": "/company/07731870/accounts/2021-08-31.pdf",
        "made_up_date": "2021-08-31",
        "period_start": "2021-08-31",
        "period_end": "2021-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "26194.00",
        "debtors": "24450.00",
        "cash_bank_in_hand": "14994.00",
        "current_assets": "39444.00",
        "creditors_due_within_one_year": "17231.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "22213.00",
        "total_assets_less_current_liabilities": "48407.00",
        "net_assets_liabilities": "28151.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "28149.00",
        "shareholder_funds": "28151.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2022.zip"
      },
      {
        "url": "/company/07731870/accounts/2020-08-31",
        "pdf_url": "/company/07731870/accounts/2020-08-31.pdf",
        "made_up_date": "2020-08-31",
        "period_start": "2020-08-31",
        "period_end": "2020-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "5663.00",
        "debtors": "19011.00",
        "cash_bank_in_hand": "7624.00",
        "current_assets": "26635.00",
        "creditors_due_within_one_year": "15473.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "11162.00",
        "total_assets_less_current_liabilities": "16825.00",
        "net_assets_liabilities": "15749.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "15747.00",
        "shareholder_funds": "15749.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2020.zip"
      },
      {
        "url": "/company/07731870/accounts/2019-08-31",
        "pdf_url": "/company/07731870/accounts/2019-08-31.pdf",
        "made_up_date": "2019-08-31",
        "period_start": "2019-08-31",
        "period_end": "2019-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "8572.00",
        "debtors": "12702.00",
        "cash_bank_in_hand": "4162.00",
        "current_assets": "16864.00",
        "creditors_due_within_one_year": "25828.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-8964.00",
        "total_assets_less_current_liabilities": "-392.00",
        "net_assets_liabilities": "-2716.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "-2718.00",
        "shareholder_funds": "-2716.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2019.zip"
      },
      {
        "url": "/company/07731870/accounts/2018-08-31",
        "pdf_url": "/company/07731870/accounts/2018-08-31.pdf",
        "made_up_date": "2018-08-31",
        "period_start": "2018-08-31",
        "period_end": "2018-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "13394.00",
        "debtors": "13925.00",
        "cash_bank_in_hand": "1185.00",
        "current_assets": "15110.00",
        "creditors_due_within_one_year": "23785.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-8675.00",
        "total_assets_less_current_liabilities": "4719.00",
        "net_assets_liabilities": "2174.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "2172.00",
        "shareholder_funds": "2174.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2019.zip"
      },
      {
        "url": "/company/07731870/accounts/2017-08-31",
        "pdf_url": "/company/07731870/accounts/2017-08-31.pdf",
        "made_up_date": "2017-08-31",
        "period_start": "2017-08-31",
        "period_end": "2017-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "32640.00",
        "debtors": "10703.00",
        "cash_bank_in_hand": "4344.00",
        "current_assets": "15047.00",
        "creditors_due_within_one_year": "35781.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-20734.00",
        "total_assets_less_current_liabilities": "11906.00",
        "net_assets_liabilities": "5238.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "5236.00",
        "shareholder_funds": "5238.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2017.zip"
      },
      {
        "url": "/company/07731870/accounts/2015-08-31",
        "pdf_url": "/company/07731870/accounts/2015-08-31.pdf",
        "made_up_date": "2015-08-31",
        "period_start": "2015-08-31",
        "period_end": "2015-08-31",
        "entity_name": "Midland Endocrine And Osteoporosis Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "39980.00",
        "debtors": "9256.00",
        "cash_bank_in_hand": "35274.00",
        "current_assets": "44530.00",
        "creditors_due_within_one_year": "14116.00",
        "creditors_due_after_one_year": "33283.00",
        "net_current_assets_liabilities": "30414.00",
        "total_assets_less_current_liabilities": "70394.00",
        "net_assets_liabilities": "29115.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "29113.00",
        "shareholder_funds": "29115.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2016.zip"
      },
      {
        "url": "/company/07731870/accounts/2014-08-31",
        "pdf_url": "/company/07731870/accounts/2014-08-31.pdf",
        "made_up_date": "2014-08-31",
        "period_start": "2014-08-31",
        "period_end": "2014-08-31",
        "entity_name": "Midland Endocrine And Osteoporosis Ltd",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "14965.00",
        "debtors": "29324.00",
        "cash_bank_in_hand": "9813.00",
        "current_assets": "39137.00",
        "creditors_due_within_one_year": "16125.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "23012.00",
        "total_assets_less_current_liabilities": "37977.00",
        "net_assets_liabilities": "34834.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "34832.00",
        "shareholder_funds": "34834.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2015.zip"
      },
      {
        "url": "/company/07731870/accounts/2013-08-31",
        "pdf_url": "/company/07731870/accounts/2013-08-31.pdf",
        "made_up_date": "2013-08-31",
        "period_start": "2013-08-31",
        "period_end": "2013-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "19541.00",
        "debtors": "6256.00",
        "cash_bank_in_hand": "45884.00",
        "current_assets": "52140.00",
        "creditors_due_within_one_year": "11602.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "40538.00",
        "total_assets_less_current_liabilities": "60079.00",
        "net_assets_liabilities": "56171.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "56169.00",
        "shareholder_funds": "56171.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2013.zip"
      },
      {
        "url": "/company/07731870/accounts/2012-08-31",
        "pdf_url": "/company/07731870/accounts/2012-08-31.pdf",
        "made_up_date": "2012-08-31",
        "period_start": "2012-08-31",
        "period_end": "2012-08-31",
        "entity_name": "Midland Endocrine and Osteoporosis Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "24559.00",
        "debtors": "4260.00",
        "cash_bank_in_hand": "7557.00",
        "current_assets": "11817.00",
        "creditors_due_within_one_year": "22981.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-11164.00",
        "total_assets_less_current_liabilities": "13395.00",
        "net_assets_liabilities": "10716.00",
        "called_up_share_capital": "2.00",
        "profit_loss_account_reserve": "10714.00",
        "shareholder_funds": "10716.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2012.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2016-08-31",
        "filing_date": "2017-02-13",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-small",
        "paper_filed": true,
        "pdf_url": "/company/07731870/accounts/2016-08-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07731870/filing-history/MzE2ODcwODMyM2FkaXF6a2N4/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07731870/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-09-19",
    "last_made_up": "2025-09-05"
  },
  "officers": [],
  "psc": [
    {
      "name": "Paula Gittoes",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3916372",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "British",
      "source": "snapshot"
    },
    {
      "name": "Dr Neil John Lloyd Gittoes",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3620989",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "United Kingdom",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-14T22:43:52.697050+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}